Preparing the Workforce That Will Shape Pharma’s Future with ISPE President & CEO Mike Martin

Hello, everyone. Welcome to the Life Science Rundown. That is the podcast where we discuss current regulatory complexities facing the life science industry and explore innovative ways to overcome those challenges. I am your host, Nicholas Catman, president and CEO of the FDA Group. Before we get started, here's a quick word about who we are. The FDA Group is a consulting firm that helps life science companies in the areas of regulatory submissions, audit projects, mock inspections, staff augmentation, and remediation. So if you ever find yourself in need, just head over to the f e a group dot com to check us out and get in touch. So today, I am speaking with Mike Martin. Hey, Mike. How are you doing? Hey. Good, Nick. It's good to see you again. Absolutely. Appreciate you, joining me on this podcast. So, before we jump into the topic, would you kindly introduce yourself? Sure. I'm, my name is Mike Martin. I'm the president and CEO for ISPE. I've been in the, life science industry for nearly forty years. Thirty plus years of that spent at Lilly, various roles around the world. And then, almost seven years in a consulting company called CAI. Also doing projects around the world. And this last year, I've been serving as ISBE's CEO, for its global organization. K. Excellent. Thank you. So today, we're gonna be talking about how can we prepare today's workforce to shape the future of pharma. So, I would say, you know, from your vantage point as ISP's president and CEO, what are the biggest forces reshaping the pharmaceutical industry today, and how are they changing the expectations for our workforce? Yeah. So, Nick, I think that the pharma industry is in a industrial revolution of sorts. So, we call it pharma four point zero, at ISPE. That's a a term that we use. But if you look at at the other industries in the world like the automotive industry, it's gone through a number of different cycles of automation. And in typical, terminology when we we describe for, industry four point zero or industrial revolution four point zero. It's usually about some type of very integrated automation with with smart devices and a lot of, very deep control systems. And I think that's where pharma is steering, lately in the last five years or so. There's a lot of advanced robotics being applied to jobs and and tasks that used to be done by operators. And even more recently, a lot of AI driving, some of the repetitive tasks, to be done by computer or by machine. And I think that's a big change for the industry. I think that's gonna accelerate. I I think, Nick, those types of, job changes drive a different skill set requirement for the people that work in our industry. And I think, like across history, some roles get eliminated as that happens and new roles get created. And then that means that the industry has …